Quick Facts

• Primary Therapeutic Domain: Relief of temporary or chronic constipation.
• Mechanism of Action: Functions as a stool lubricant to ease the passage of contents.
• Secondary Use: Component in emollients for managing dry skin conditions.

---

Paraffin Liquid PSM is an agent used to address the symptoms of constipation, a condition characterized by infrequent or difficult bowel movements. Its primary utility lies in acting as a lubricant to help soften the stool mass and facilitate movement through the intestines.

This medication may be considered for individuals experiencing difficulty with evacuation, including in contexts such as management following certain surgical procedures or in the care of bed-ridden patients. It is also utilized in certain formulations as a topical emollient for the skin. In this capacity, it is intended to help prevent moisture loss, which supports hydration and promotes the management of various dry skin conditions.

Paraffin Liquid (also known as mineral oil) has a long history of application as a therapeutic option for these gastrointestinal and dermatological issues.

Who Can and Cannot Use Paraffin Liquid PSM

Regulatory documents strictly define the populations eligible to use this combination medicine (Liquid Paraffin and Magnesium Oxide). Use is primarily established for adults and adolescents aged 12 years and over who do not have any specific contraindications.

---

Populations Not Recommended or Contraindicated

Category	Regulatory Status	Basis for Restriction
Children under 12	Not Recommended	Risk of aspiration (lipoid pneumonia) and sensitivity to magnesium.
Pregnancy/Lactation	Not Advised	Safety is not established; potential for fat-soluble vitamin malabsorption.
Severe Renal Impairment	Contraindicated	Risk of hypermagnesemia (magnesium accumulation).

---

Absolute Contraindications (Must Not Use)

This medicine is strictly contraindicated for individuals with specific pre-existing gastrointestinal conditions, as these may pose significant risks or mask serious pathology. This includes patients with intestinal obstruction, faecal impaction, abdominal pain of unknown origin, and inflammatory bowel diseases (such as Crohn’s Disease or Ulcerative Colitis).

Restricted Use and Precautions

Caution is specifically advised for older adults and patients who are frail, bedridden, or have dysphagia (difficulty swallowing). This restriction is due to the increased risk of accidental aspiration of the liquid preparation.

Paraffin Liquid PSM has a documented interaction profile governed by the properties of its two active components. The Magnesium Oxide component acts as a polyvalent cation and antacid, leading to pharmacokinetic interactions by either chemically binding to or altering the solubility of co-administered oral medications. This results in reduced systemic exposure (lower plasma levels) for agents such as Tetracyclines, Fluoroquinolone antibiotics, and Bisphosphonates.

Regulatory requirements mandate a timing separation of at least two hours between this product and most interacting oral medications to mitigate absorption interference. Specific protocols for certain highly sensitive drugs, like Dolutegravir and Sotorasib, require even longer separation intervals.

The Liquid Paraffin component introduces a distinct interaction by physically interfering with the absorption of fat-soluble substances from the gut. This interaction may result in reduced effectiveness of fat-soluble vitamins (A, D, E, K), oral contraceptives, and certain anticoagulants.

Furthermore, systemic absorption of magnesium creates a pharmacodynamic interaction risk. In patients with renal impairment, clearance is reduced, leading to the risk of hypermagnesaemia and documented central nervous system (CNS) depression. This interaction-related constraint is specifically noted in official labeling. Certain combinations, like co-administration with Eltrombopag, are designated as formally contraindicated due to the severe reduction in the other drug's exposure.

How Paraffin Liquid PSM works: Mechanism of Action

Physical Lubrication and Emollience of Fecal Mass

Paraffin Liquid PSM acts as a physical lubricant and emollient, engaging with the fecal matter in the gastrointestinal tract lumen. This interaction is non-chemical, involving the physical penetration and coating of the stool mass to soften its consistency and reduce internal friction. The primary physiological consequence is the reduction of mechanical force required for the transit and elimination of colonic contents.

Impedance of Colonic Water Reabsorption

The drug forms a physical, non-absorbable oil layer over the intestinal mucosa, creating a barrier. This barrier impedes the normal physiological process of water reabsorption from the stool back across the colonic epithelium. The resulting physiological change is the retention of critical moisture within the colon, leading to a softer, more pliable stool mass with modified passage mechanics.

Non-Systemic Peripheral Action

The substance is minimally absorbed and metabolically inert, restricting its activity to the peripheral GI tract lumen without engaging central nervous system pathways or systemic targets. This mechanism localizes the physiological modulation to the gastrointestinal lumen, confining the physiological change to the fecal elimination process.

The product is formulated as an Oral Suspension and is administered exclusively by ingestion. Dosing regimens vary based on the intended use, reflecting the dual action of its components.

For the purpose of constipation relief, the standard adult dose is typically 15 mL to 30 mL of the oral suspension, taken once daily, often at bedtime or before breakfast. The laxative dose is typically consumed with a full glass of liquid to support the intended physical action. Use for this purpose is designated as a short-term intervention, and the maximum duration is three consecutive days.

Conversely, when used for acid discomfort, the standard dose is lower, generally 5 mL to 10 mL, which may be repeated as necessary, provided the total volume does not exceed the maximum daily limit of 60 mL in any 24 hours.

Administration requires that the bottle be shaken well before use to ensure component uniformity. While the adult regimen includes older adults, pediatric use for children over two years involves a lower, age-specific dose, such as 5 mL to 15 mL. This structure follows standard parameters for route, dose, frequency, timing, and duration.

Research evidence / Overview of studies for Paraffin Liquid PSM

---

Evidence for Use in Constipation (Lubricant and Osmotic Action)

The research on this medicine's components—Liquid Paraffin and Magnesium Oxide—was evaluated in studies exploring outcomes related to constipation, a condition marked by functional limitations and periods of heightened symptoms. Randomized Controlled Trials (RCTs) have been a common study design, along with systematic reviews that combine data from multiple clinical studies. Research has explored outcomes related to physical discomfort, such as changes in stool frequency and stool consistency (using standardized scales).

Studies monitored responses in various groups, including children with chronic or functional constipation, as well as adults who was observed in separate trials focusing on the Magnesium Oxide component. However, the certainty remains low for the overall body of evidence. Studies generally had follow-up durations that were limited, often lasting only 4 to 8 weeks. There is also limited information for long-term outcomes or the durability of observations over extended periods.

---

Research Evidence for Antacid Relief

Evidence for the antacid application of the Magnesium Oxide component was derived from bibliographic and pharmacological studies that examine its physical-chemical properties. This use was evaluated in studies examining its capacity for neutralization of gastric acid in the upper digestive tract. Evidence for this component is consistent with regulatory acceptance based on established use.

Findings describe how quickly the neutralization capacity of the magnesium salt component was observed following administration. The component’s well-established use is documented in regulatory reviews and existing bibliographic literature related to acid discomfort. The key limitation is that the evidence relies mainly on these established principles rather than recent, large-scale, controlled trials.

---

Evidence in Specific Patient Groups and Research Gaps

Specific research has explored outcomes in certain groups, particularly children with functional constipation. Conversely, data for certain groups remain insufficient. For instance, there is limited information for older adults in combination product trials, or for individuals with specific comorbidities. The available evidence describes group patterns, but the results apply only to the populations studied, meaning findings for certain subgroups are uncertain due to modest sample sizes in relevant trials.

Key gaps include the need for more controlled trials that specifically examine the outcomes of the Liquid Paraffin and Magnesium Oxide combination. Research provides context but not individual predictions, and the evidence quality varies across studies, particularly for the laxative indications.

Key Studies & References NICE Guideline NG112: Constipation in children and young people: diagnosis and management (relevant section on laxatives)

Common questions about Paraffin Liquid PSM (FAQ)

Q: How does Paraffin Liquid PSM differ from stimulant or fiber laxatives?

A: The official information describes this product as having a dual action: it acts as a physical lubricant to soften stool and as an osmotic agent to retain water in the bowel. This mechanism is distinct from bulk-forming laxatives, which increase stool volume, and stimulant laxatives, which promote intestinal muscle contractions.

Q: How long does it typically take for Paraffin Liquid PSM to start showing its effects?

A: The onset of the laxative effect, according to regulatory knowledge for this therapeutic class, often occurs within 30 minutes to 6 hours. This time frame can vary among individuals, as individual results may vary.

Q: Does Paraffin Liquid PSM interact with common over-the-counter medications?

A: Yes, official documentation indicates that the magnesium component can lead to pharmacokinetic interactions by altering the absorption of other medications. This includes certain common over-the-counter drugs such as aspirin, cimetidine, and ranitidine. Official guidance often recommends a timing separation between doses to help mitigate this effect.

Q: What type of adverse events should prompt a person to stop using Paraffin Liquid PSM immediately?

A: Regulatory guidance emphasizes seeking medical attention if severe adverse events are experienced. This includes signs of an allergic reaction (like rash or hives), rectal bleeding, severe dizziness, mental changes, or extreme weakness. Discontinuing use and seeking medical advice is recommended if symptoms persist or worsen.

Q: Is Paraffin Liquid PSM considered a high-risk medication by regulators?

A: Regulatory documents describe the product’s safety profile by listing specific risks and contraindications rather than assigning a single, qualitative risk level. Serious concerns cited in official labeling include the potential for lipoid pneumonia from accidental inhalation and severe hypermagnesaemia (magnesium overload), especially in patients with existing kidney issues.

Q: Are there different forms or strengths of Paraffin Liquid PSM available?

A: According to the official product information, Paraffin Liquid PSM is approved as an Oral Suspension containing a fixed combination and strength of the two active ingredients. Different strengths of this specific combination product may not be available.

Q: Why does the official guidance often recommend against taking Paraffin Liquid PSM right before bed?

A: Official precautions advise against administering the liquid immediately before lying down or going to sleep. This is primarily due to the risk of accidental aspiration (inhaling the oil), which carries the risk of serious lung complications like lipoid pneumonia.

Q: What non-medicinal ingredients are typically found in Paraffin Liquid PSM products?

A: The full list of non-medicinal ingredients, which are referred to as excipients, is included in the official product information. This list is detailed in a dedicated section, typically Section 6.1 of the Summary of Product Characteristics (SmPC).

Q: Does Paraffin Liquid PSM contain any sugar, gluten, or common allergens?

A: Information regarding the presence of sugar, gluten, or specific allergens in the final product is contained within the detailed list of excipients (inactive ingredients). This information is typically reviewed in the official patient information leaflet or product label.

Q: Is Paraffin Liquid PSM considered to be habit-forming or addictive?

A: While the product is not classified as an addictive substance, regulatory warnings advise against use for more than a short duration. Prolonged or habitual use is not recommended due to the potential for the body to become dependent on the laxative effect.

Q: What is the shelf life of an opened bottle of Paraffin Liquid PSM?

A: For liquid formulations, the official labeling dictates a specific in-use stability period, which is the amount of time the product maintains its stability after the container is first opened. This specific shelf life is listed in the Storage or Shelf Life section of the official product information.

Q: Why is simultaneous use with certain mineral supplements not recommended?

A: The official information advises against simultaneous use with certain mineral supplements due to the high amount of magnesium already present in the product. Taking additional magnesium or polyvalent cations may increase the risk of developing hypermagnesaemia (dangerously high magnesium levels), especially if kidney function is reduced.

Q: What are the general expectations for frequency of bowel movements when using this medicine?

A: The product is indicated for the temporary relief of occasional symptoms. Official guidelines indicate that if the desired effect is not achieved or if symptoms persist or worsen after the recommended short duration of use (typically 3–7 days depending on the jurisdiction), discontinuation of the product and seeking medical advice is often advised.

Q: Are there any known interactions between Paraffin Liquid PSM and herbal remedies?

A: Official guidance advises that patients inform their healthcare provider about all products, including herbal remedies, being used. This is due to the potential for the active components to interact with certain herbal substances, particularly concerning absorption.

Q: Is Paraffin Liquid PSM available over the counter or does it require a prescription?

A: According to the regulatory classification of its active ingredients, this product is generally categorized for nonprescription (over-the-counter or OTC) use. This status is granted provided the product complies with the requirements of the relevant regulatory monograph.

Q: How does a person know if their symptoms are too severe for Paraffin Liquid PSM to address?

A: The product is strictly contraindicated (must not be used) if certain severe symptoms are present, such as abdominal pain of unknown origin, signs of intestinal obstruction, or acute inflammatory bowel disease. These conditions suggest that symptoms may be too severe and warrant discussion with a healthcare provider immediately.

Q: Are there any restrictions on driving or operating machinery while using Paraffin Liquid PSM?

A: Official product information addresses the safety for performing common tasks. Regulatory documents state that there are no known adverse effects on the ability to drive or operate machinery listed for this product.

Q: What does the patient information leaflet usually describe as the risk of overdose?

A: Official labeling on the risk of overdose describes that consuming excessive amounts may result in severe diarrhea, vomiting, profound weakness, and extreme drowsiness. These symptoms are linked to the risk of magnesium toxicity (hypermagnesaemia).

Q: Can Paraffin Liquid PSM be mixed with juices or other liquids?

A: Yes, to help with the consumption of the oral suspension and ensure adequate hydration, the dose may be mixed with water or other liquids, such as fruit juice, as explicitly directed by the product label.

Q: Are there alternative names for Paraffin Liquid PSM used in different countries?

A: The specific product name will vary across international markets, but the active ingredients have standard global names. For instance, Liquid Paraffin is also known in regulatory texts as Mineral Oil or Paraffinum Liquidum.

Storage and Disposal of Paraffin Liquid PSM

Official regulatory labeling dictates strict conditions for the storage and disposal of drug products containing Paraffin Liquid and Magnesium Oxide.

---

Storage Requirements

• Temperature and Light: The medicine must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). It must be protected from light and direct sunlight. The product must not be frozen or exposed to excessive heat above 30 C (86 F).
• Container Integrity: The product must be kept in its original container with the lid tightly closed to prevent contamination and maintain stability until the expiration date.
• Child Safety: All labeling mandates that the medicine be kept out of the sight and reach of children.

---

Disposal Instructions

Disposal of unused or expired Paraffin Liquid PSM must be carried out according to local regulations. Medicine should not be thrown away via household waste or wastewater (e.g., down the sink or toilet); instead, consult a pharmacist or local waste authority for proper disposal procedures.